Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Cipla
Johnson and Johnson
Colorcon
Accenture
Express Scripts
Federal Trade Commission

Generated: April 25, 2018

DrugPatentWatch Database Preview

ORABLOC Drug Profile

« Back to Dashboard

Which patents cover Orabloc, and when can generic versions of Orabloc launch?

Orabloc is a drug marketed by Pierrel and is included in one NDA.

The generic ingredient in ORABLOC is articaine hydrochloride; epinephrine bitartrate. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the articaine hydrochloride; epinephrine bitartrate profile page.

US Patents and Regulatory Information for ORABLOC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pierrel ORABLOC articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 022466-001 Feb 26, 2010 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pierrel ORABLOC articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 022466-002 Feb 26, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chubb
Healthtrust
Fish and Richardson
Mallinckrodt
Cipla
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.